+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Colloidal Gold Immunochromatographic Assay POCT Market - Global Forecast 2026-2032- Product Image
Colloidal Gold Immunochromatographic Assay POCT Market - Global Forecast 2026-2032- Product Image
Sale

Colloidal Gold Immunochromatographic Assay POCT Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6146107
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Colloidal Gold Immunochromatographic Assay POCT Market is projected to reach USD 1.41 Billion in 2026. It is expected to continue growing at a CAGR of 7.30%, reaching USD 2.15 Billion by 2032.

Colloidal Gold Immunochromatographic Assay POCT: Executive Overview

Colloidal gold immunochromatographic assays are rapid, visually interpreted point-of-care tests that support decentralized screening and near-patient decision-making. Their relevance is strongest where laboratories are distant, turnaround time is clinically important, and workflows must remain simple. Adoption depends on analytical performance, specimen handling, quality assurance, regulatory compliance, affordability, and integration with referral pathways. Use cases span infectious disease screening, pregnancy testing, cardiometabolic assessment, and other applications where rapid immunochemical results can guide immediate action.

Decentralized Care and Quality Requirements Are Reshaping Adoption

Healthcare delivery is shifting toward community clinics, pharmacies, emergency settings, mobile services, and home-based testing. This broadens demand for assays that require limited equipment and provide results within a short operational window. At the same time, purchasers are placing greater emphasis on documented sensitivity and specificity, lot consistency, operator training, internal controls, traceability, and safe disposal. The competitive environment is therefore moving beyond test availability toward dependable performance across varied users and settings. Connectivity, external quality assessment, and clear interpretation procedures are increasingly important when rapid results influence treatment or referral decisions.

Artificial Intelligence Adds Value Through Interpretation and Workflow Integration

Artificial intelligence can strengthen colloidal gold immunochromatographic testing when paired with smartphone imaging, reader devices, and secure data systems. Image analysis may help standardize line interpretation, flag invalid tests, document results, and support semi-quantitative assessment where validated. AI-enabled workflows can also assist triage, inventory planning, quality monitoring, and linkage of decentralized results to electronic records. These benefits remain dependent on representative training data, calibrated hardware, cybersecurity, privacy safeguards, human oversight, and prospective clinical validation. AI should complement-not replace-assay controls, clinician judgment, or confirmatory testing when results are uncertain.

Regional Insights: Access Expansion Must Be Matched by Assurance

North America emphasizes regulatory evidence, interoperability, reimbursement considerations, and use in urgent, community, and home settings. Latin America presents opportunities linked to decentralized access and infectious-disease programs, while procurement constraints and uneven laboratory capacity make robust distribution and training essential. Europe prioritizes performance evaluation, quality systems, sustainability, and alignment with evolving diagnostic regulation. The Middle East is characterized by investments in healthcare infrastructure, centralized procurement in some systems, and demand for rapid testing across hospitals, travel, and remote settings. Africa benefits from tools suited to decentralized and resource-constrained environments, with supply continuity, external quality assessment, and confirmatory referral networks remaining critical. Asia-Pacific combines advanced healthcare markets with large, diverse populations and rural access challenges, creating varied requirements for connectivity, affordability, local validation, and scalable service delivery.

Group Insights: Regional Blocs Influence Procurement and Standards

ASEAN markets commonly require adaptable distribution, multilingual instructions, and strategies that address differences in regulatory maturity and health-system access. BRICS economies combine substantial domestic health needs with varied manufacturing, procurement, and regulatory capabilities, encouraging localization and resilient supply chains. The European Union places strong weight on harmonized compliance, clinical evidence, post-market surveillance, and responsible data practices. G7 systems generally demand high-quality validation, established laboratory networks, and integration with digital health infrastructure. GCC markets often emphasize centralized purchasing, rapid deployment, and high service reliability in hospital and public-health settings. NATO countries are not a single healthcare market, but shared preparedness priorities can increase interest in interoperable, field-deployable diagnostics for civilian resilience and emergency response.

Country Insights: Diverse Priorities Across Leading Health Systems

Australia values decentralized access across geographically dispersed communities, with validation and supply reliability especially important outside major cities. Brazil requires solutions suited to a large and heterogeneous health system, including public-sector procurement and regional access. Canada’s geography supports demand for near-patient testing, while provincial pathways and evidence requirements shape adoption. China combines large-scale screening capacity with strong expectations for regulatory compliance, manufacturing quality, and digital integration. France, Germany, Italy, and Spain operate within European regulatory frameworks while differing in procurement, reimbursement, and point-of-care implementation practices. India’s diverse care settings favor affordable, robust tests supported by training and referral systems. Japan emphasizes precision, reliability, workflow discipline, and aging-care applications. Mexico’s decentralized and public-health needs make distribution, affordability, and quality assurance central. Russia’s adoption environment is influenced by domestic supply considerations, regulatory processes, and access across geographically broad regions. South Korea combines advanced digital infrastructure with high expectations for validated performance. The United Kingdom prioritizes evidence, governance, and integration across primary, acute, and community care. The United States presents opportunities across hospitals, pharmacies, clinics, and home settings, subject to regulatory authorization, reimbursement, usability, and data-integration requirements.

Action Priorities for Leaders: Build Trust, Resilience, and Clinical Utility

Industry leaders should first define the clinical decision each assay is intended to support and validate performance in the actual populations, specimen types, and operating conditions of use. They should establish transparent quality systems covering manufacturing, lot release, stability, user training, invalid-result handling, and post-market surveillance. Distribution strategies should combine reliable supply, temperature and storage controls, local service capability, and clear referral pathways. Digital features should be introduced only where they solve a documented workflow problem, with privacy, cybersecurity, interoperability, and algorithmic validation built in from the start. Partnerships with laboratories, public-health agencies, clinicians, and community providers can improve implementation, while sustainability efforts should address packaging, waste, and responsible procurement.

Research Methodology: Evidence-Led Assessment of Decentralized Diagnostics

This executive summary uses a structured assessment of the colloidal gold immunochromatographic assay point-of-care testing landscape. The approach considers assay principles, clinical and public-health applications, user environments, regulatory expectations, procurement dynamics, digital integration, supply-chain requirements, and implementation barriers. Regional, group, and country perspectives are synthesized from publicly available health-system characteristics, diagnostic governance frameworks, laboratory-access conditions, and documented point-of-care practices. Claims are limited to qualitative, evidence-based insights; no market estimates, shares, sizing, or forecasts are presented. Interpretation should be supplemented with product-specific analytical and clinical validation, local regulatory review, and current procurement evidence.

Conclusion: Reliable Rapid Testing Will Depend on More Than Speed

Colloidal gold immunochromatographic assays remain relevant because they can bring simple immunochemical testing closer to patients and frontline decisions. Their long-term value will depend on dependable analytical performance, appropriate clinical use, equitable access, and integration with confirmation and care pathways. Regional and country conditions require differentiated implementation rather than a single global model. Artificial intelligence may improve interpretation and data utility, but only when governed by rigorous validation and responsible data practices. Leaders that combine product quality with operational resilience, workforce support, and measurable clinical utility will be best positioned to strengthen point-of-care testing.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Colloidal Gold Immunochromatographic Assay POCT Market, by Product
7.1. Introduction
7.2. Card
7.3. Cassette
7.4. Strip
8. Colloidal Gold Immunochromatographic Assay POCT Market, by Technology
8.1. Introduction
8.2. Colorimetric Immunoassay
8.3. Fluorescent Immunoassay
8.4. Lateral Flow Assay
8.5. Multiplex Assay
9. Colloidal Gold Immunochromatographic Assay POCT Market, by Sample Type
9.1. Introduction
9.2. Saliva
9.3. Serum And Plasma
9.4. Urine
9.5. Whole Blood
10. Colloidal Gold Immunochromatographic Assay POCT Market, by Application
10.1. Introduction
10.2. Cardiac Markers
10.2.1. BNP/NT-proBNP
10.2.2. CK-MB
10.2.3. Myoglobin
10.2.4. Troponin I/T
10.3. Drug Abuse
10.3.1. Amphetamines
10.3.2. Cannabinoids
10.3.3. Cocaine
10.3.4. Opiates
10.4. Infectious Disease
10.4.1. COVID-19
10.4.2. Hepatitis
10.4.3. HIV
10.4.4. Influenza
10.4.5. Malaria
10.5. Pregnancy & Fertility
10.5.1. Fertility Test
10.5.2. Pregnancy Test
10.6. Tumor Markers
10.6.1. AFP
10.6.2. CA125
10.6.3. CA19-9
10.6.4. CEA
10.6.5. PSA
11. Colloidal Gold Immunochromatographic Assay POCT Market, by End-User
11.1. Introduction
11.2. Home Care Settings
11.3. Hospital Laboratory
11.4. Point Of Care Centers
11.5. Reference Laboratories
12. Colloidal Gold Immunochromatographic Assay POCT Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Colloidal Gold Immunochromatographic Assay POCT Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Colloidal Gold Immunochromatographic Assay POCT Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Becton, Dickinson and Company
16.3. Beijing Hotgen Biotech Co., Ltd.
16.4. BioMérieux SA
16.5. Danaher Corporation
16.6. F. Hoffmann-La Roche AG
16.7. Intec Products, Inc.
16.8. Meridian Bioscience, Inc.
16.9. OraSure Technologies, Inc.
16.10. PerkinElmer, Inc.
16.11. Quidel Corporation
16.12. Thermo Fisher Scientific Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Colloidal Gold Immunochromatographic Assay POCT Market, Years Considered for the Study
FIGURE 2. Global Colloidal Gold Immunochromatographic Assay POCT Market, Research Design
FIGURE 3. Global Colloidal Gold Immunochromatographic Assay POCT Market, Research Framework
FIGURE 4. Global Colloidal Gold Immunochromatographic Assay POCT Market, Data Triangulation
FIGURE 5. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 15. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Colloidal Gold Immunochromatographic Assay POCT Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Colloidal Gold Immunochromatographic Assay POCT Market Segmentation & Coverage
TABLE 2. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, 2017-2032 (USD Million)
TABLE 3. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Card Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Card Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Card Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Cassette Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Cassette Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Cassette Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Strip Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Strip Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Strip Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 14. Global Colorimetric Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Colorimetric Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Colorimetric Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Fluorescent Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Fluorescent Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Fluorescent Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Lateral Flow Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Lateral Flow Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Lateral Flow Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Multiplex Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Multiplex Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Multiplex Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 27. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Serum And Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Serum And Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Serum And Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 40. Global Cardiac Markers Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Cardiac Markers Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Cardiac Markers Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global BNP/NT-proBNP Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global BNP/NT-proBNP Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global BNP/NT-proBNP Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global CK-MB Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global CK-MB Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global CK-MB Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Myoglobin Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Myoglobin Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Myoglobin Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Troponin I/T Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Troponin I/T Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Troponin I/T Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Drug Abuse Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Drug Abuse Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Drug Abuse Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Amphetamines Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Amphetamines Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Amphetamines Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Cannabinoids Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Cannabinoids Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Cannabinoids Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Cocaine Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Cocaine Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Cocaine Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Opiates Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Opiates Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Opiates Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global COVID-19 Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global COVID-19 Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global COVID-19 Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Hepatitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Hepatitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Hepatitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global HIV Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global HIV Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global HIV Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Influenza Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Influenza Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Influenza Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Malaria Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Malaria Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Malaria Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Pregnancy & Fertility Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Pregnancy & Fertility Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Pregnancy & Fertility Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Fertility Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Fertility Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Fertility Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Pregnancy Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Pregnancy Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Pregnancy Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Tumor Markers Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Tumor Markers Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Tumor Markers Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global AFP Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global AFP Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global AFP Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global CA125 Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global CA125 Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global CA125 Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global CA19-9 Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global CA19-9 Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global CA19-9 Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global CEA Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global CEA Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global CEA Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global PSA Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global PSA Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global PSA Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 116. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Hospital Laboratory Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Hospital Laboratory Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Hospital Laboratory Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Point Of Care Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Point Of Care Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Point Of Care Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Colloidal Gold Immunochromatographic Assay POCT Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 140. North America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. North America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 142. North America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 143. North America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 144. North America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. North America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 146. North America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 147. North America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 148. North America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 149. North America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 150. North America Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 151. Latin America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Latin America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 153. Latin America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 154. Latin America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 155. Latin America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Latin America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 157. Latin America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 158. Latin America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 159. Latin America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 160. Latin America Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 161. Latin America Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 162. Europe Colloidal Gold Immunochromatographic Assay POCT Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Europe Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 164. Europe Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. Europe Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 166. Europe Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. Europe Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 168. Europe Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 169. Europe Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 170. Europe Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 171. Europe Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 172. Europe Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 173. Middle East Colloidal Gold Immunochromatographic Assay POCT Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Middle East Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 175. Middle East Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 176. Middle East Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 177. Middle East Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. Middle East Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 179. Middle East Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 180. Middle East Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 181. Middle East Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 182. Middle East Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 183. Middle East Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 184. Africa Colloidal Gold Immunochromatographic Assay POCT Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Africa Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 186. Africa Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 187. Africa Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 188. Africa Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. Africa Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 190. Africa Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 191. Africa Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 192. Africa Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 193. Africa Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 194. Africa Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 195. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. ASEAN Colloidal Gold Immunochromatographic Assay POCT Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. ASEAN Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 198. ASEAN Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 199. ASEAN Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 200. ASEAN Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. ASEAN Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 202. ASEAN Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 203. ASEAN Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 204. ASEAN Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 205. ASEAN Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 206. ASEAN Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 207. GCC Colloidal Gold Immunochromatographic Assay POCT Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. GCC Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 209. GCC Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 210. GCC Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 211. GCC Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. GCC Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 213. GCC Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 214. GCC Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 215. GCC Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 216. GCC Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 217. GCC Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 218. European Union Colloidal Gold Immunochromatographic Assay POCT Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. European Union Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 220. European Union Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 221. European Union Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 222. European Union Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 223. European Union Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 224. European Union Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 225. European Union Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 226. European Union Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 227. European Union Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 228. European Union Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 229. BRICS Colloidal Gold Immunochromatographic Assay POCT Market Size, by Group, 2017-2032 (USD Million)
TABLE 230. BRICS Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 231. BRICS Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 232. BRICS Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 233. BRICS Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. BRICS Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 235. BRICS Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 236. BRICS Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 237. BRICS Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 238. BRICS Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 239. BRICS Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 240. G7 Colloidal Gold Immunochromatographic Assay POCT Market Size, by Group, 2017-2032 (USD Million)
TABLE 241. G7 Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 242. G7 Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 243. G7 Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 244. G7 Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. G7 Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 246. G7 Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 247. G7 Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 248. G7 Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 249. G7 Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 250. G7 Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 251. NATO Colloidal Gold Immunochromatographic Assay POCT Market Size, by Group, 2017-2032 (USD Million)
TABLE 252. NATO Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 253. NATO Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 254. NATO Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 255. NATO Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. NATO Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 257. NATO Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 258. NATO Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 259. NATO Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 260. NATO Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 261. NATO Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 262. Global Colloidal Gold Immunochromatographic Assay POCT Market Size, by Country, 2017-2032 (USD Million)
TABLE 263. United States Colloidal Gold Immunochromatographic Assay POCT Market Size, 2017-2032 (USD Million)
TABLE 264. United States Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 265. United States Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 266. United States Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 267. United States Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. United States Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 269. United States Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 270. United States Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 271. United States Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 272. United States Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 273. United States Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 274. Canada Colloidal Gold Immunochromatographic Assay POCT Market Size, 2017-2032 (USD Million)
TABLE 275. Canada Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 276. Canada Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 277. Canada Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 278. Canada Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. Canada Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 280. Canada Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 281. Canada Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 282. Canada Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 283. Canada Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 284. Canada Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 285. Mexico Colloidal Gold Immunochromatographic Assay POCT Market Size, 2017-2032 (USD Million)
TABLE 286. Mexico Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 287. Mexico Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 288. Mexico Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 289. Mexico Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. Mexico Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 291. Mexico Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 292. Mexico Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 293. Mexico Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 294. Mexico Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 295. Mexico Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 296. Brazil Colloidal Gold Immunochromatographic Assay POCT Market Size, 2017-2032 (USD Million)
TABLE 297. Brazil Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 298. Brazil Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 299. Brazil Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 300. Brazil Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 301. Brazil Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 302. Brazil Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 303. Brazil Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 304. Brazil Colloidal Gold Immunochromatographic Assay POCT Market Size, by Pregnancy & Fertility, 2017-2032 (USD Million)
TABLE 305. Brazil Colloidal Gold Immunochromatographic Assay POCT Market Size, by Tumor Markers, 2017-2032 (USD Million)
TABLE 306. Brazil Colloidal Gold Immunochromatographic Assay POCT Market Size, by End-User, 2017-2032 (USD Million)
TABLE 307. United Kingdom Colloidal Gold Immunochromatographic Assay POCT Market Size, 2017-2032 (USD Million)
TABLE 308. United Kingdom Colloidal Gold Immunochromatographic Assay POCT Market Size, by Product, 2017-2032 (USD Million)
TABLE 309. United Kingdom Colloidal Gold Immunochromatographic Assay POCT Market Size, by Technology, 2017-2032 (USD Million)
TABLE 310. United Kingdom Colloidal Gold Immunochromatographic Assay POCT Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 311. United Kingdom Colloidal Gold Immunochromatographic Assay POCT Market Size, by Application, 2017-2032 (USD Million)
TABLE 312. United Kingdom Colloidal Gold Immunochromatographic Assay POCT Market Size, by Cardiac Markers, 2017-2032 (USD Million)
TABLE 313. United Kingdom Colloidal Gold Immunochromatographic Assay POCT Market Size, by Drug Abuse, 2017-2032 (USD Million)
TABLE 314. United Kingdom Colloidal Gold Immunochromatographic Assay POCT Market Size, by Infectious Disease, 2017-20

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Beijing Hotgen Biotech Co., Ltd.
  • BioMérieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Intec Products, Inc.
  • Meridian Bioscience, Inc.
  • OraSure Technologies, Inc.
  • PerkinElmer, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Colloidal Gold Test Readers Market - Global Forecast 2026-2032 - Product Image

Colloidal Gold Test Readers Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Multi-Channel Colloidal Gold Immunochromatography Analyzer Market - Global Forecast 2026-2032 - Product Image

Multi-Channel Colloidal Gold Immunochromatography Analyzer Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Point-of-Care-Testing (POCT) Market Report 2026 - Product Image

Point-of-Care-Testing (POCT) Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Gold Infused Beauty Product Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Gold Infused Beauty Product Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
Blood Viscometer Market Size, Share & Trends Analysis Report by Product (Capillary Viscometers, Rotational Viscometers, Microfluidic Viscometers), Application (Clinical Diagnostics, Point-of-Care Testing (POCT), End Use and Region with Growth Forecasts, 2025-2033 - Product Image

Blood Viscometer Market Size, Share & Trends Analysis Report by Product (Capillary Viscometers, Rotational Viscometers, Microfluidic Viscometers), Application (Clinical Diagnostics, Point-of-Care Testing (POCT), End Use and Region with Growth Forecasts, 2025-2033

  • Report
  • 105 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.